Personalized cell therapy - for the treatment of advanced-stage cancer.
Personalized cell therapy – for all cancers
TSeqCure Immunology is a Stockholm-based company that develops SeqCureNEO, a personalized cell therapy product for the treatment of advanced-stage cancer.
The SeqCureNEO cell product is created from the patient’s own immune cells, isolated from a blood sample. Through our proprietary culturing process, the cells are cultured and modified to react against the patient’s individual tumor mutations. No genetic engineering – only enrichment and strengthening of the weak anti-tumor immune response that already exists in the patient.
Contact: info@seqcureimmunology.com
Read more about SeqCure Immunology here.
Follow SeqCure Immunology on LinkedIn here.